Crossref
Stopping GLP-1 treatment could double risk of heart attack, stroke, or death, study finds
BMJ · 10.11.2026 · 395 · e101418
DOI: 10.1136/bmj-2026-101418 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMJ, online erschienen am 10.11.2026. Verfasst von Rosa Furneaux. Beteiligte Einrichtung: The BMJ. Die Arbeit nennt 1 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- The BMJ.
Zitieren
APA
Furneaux, R. (2026). Stopping GLP-1 treatment could double risk of heart attack, stroke, or death, study finds. BMJ, 395, e101418. https://doi.org/10.1136/bmj-2026-101418
Vancouver
Furneaux R. Stopping GLP-1 treatment could double risk of heart attack, stroke, or death, study finds. BMJ. 2026;395:e101418. doi:10.1136/bmj-2026-101418
BibTeX
@article{Furneaux2026,
author = {Furneaux, Rosa},
title = {Stopping GLP-1 treatment could double risk of heart attack, stroke, or death, study finds},
journal = {BMJ},
year = {2026},
volume = {395},
pages = {e101418},
doi = {10.1136/bmj-2026-101418}
}
EUVIMED